Loading clinical trials...
Loading clinical trials...
This is a multicenter, randomized, blinded, placebo-controlled study to assess the effects on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes. Patients will be random...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AstraZeneca
NCT02088658 · Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, and more
NCT02113163 · Diabetes Mellitus, Non-Insulin-Dependent, Hypertriglyceridemia
NCT00004992 · Diabetes Mellitus, Non-Insulin-Dependent, Glucose Intolerance
NCT02541734 · Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus
NCT00545584 · Diabetes Mellitus, Non-Insulin-Dependent
Pinnacle Research Group
Anniston, Alabama
Parkway Medical Center
Birmingham, Alabama
Alabama Clinical Therapeutics
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions